Evaluation of a real-time PCR assay performance to detect Mycobacterium tuberculosis, rifampicin, and isoniazid resistance in sputum specimens: a multicenter study in two major cities of Indonesia
- PMID: 38800757
- PMCID: PMC11123600
- DOI: 10.3389/fmicb.2024.1372647
Evaluation of a real-time PCR assay performance to detect Mycobacterium tuberculosis, rifampicin, and isoniazid resistance in sputum specimens: a multicenter study in two major cities of Indonesia
Abstract
Background: Tuberculosis (TB) is one of the major global health issues due to its high mortality rate, especially in low- and middle-income countries. One of the key success points of the TB eradication program is early TB diagnosis, which requires rapid and accurate diagnostic testing. This study aimed to evaluate the performance of a newly developed RT-PCR kit (Indigen MTB/DR-TB RT-PCR) in a routine TB clinical setting.
Method: A multi-fluorescence RT-PCR assay was designed and developed to detect regions within IS6110, rpoB, katG, and inhA of the Mycobacterium tuberculosis (MTB) genes. Sputum specimens were obtained from suspected TB patients who visited TB healthcare facilities in two major cities of Indonesia from September 2022 to May 2023. Specimens were assessed using Indigen MTB/DR-TB RT-PCR, acid-fast bacillus (AFB) smear microscopy, MTB culture, and drug susceptibility testing (DST) methods. Fisher's exact test (χ2) was used to analyze the Indigen performance relative to culture methods.
Result: The performance of Indigen MTB/DR-TB RT-PCR to detect MTB was assessed using 610 sputum specimens obtained from suspected patients. The overall sensitivity and specificity were 94.12% (95% CI: 90.86-96.48%) and 98.32% (95% CI: 96.20-99.46%), respectively. When the analysis was performed on AFB smear-negative TB subjects (386 subjects), a lower sensitivity level was found at 78.57% (95% CI: 68.26-86.78%), while the specificity level remained similar at 98.34% (95% CI: 96.18-99.46%). The overall performance of Indigen MTB/DR-TB RT-PCR to detect MTB showed substantial agreement with the MTB culture method (kappa value 0.93). In comparison to DST, the sensitivity and specificity levels of Indigen to detect RIF resistance or INH resistance were 78.2% (95% CI: 61.8-90.2%) and 82.8% (95% CI: 64.2-94.2%), respectively, while the specificity level for both groups was at 100% (95% CI, 87.7-100%).
Conclusion: Indigen MTB/DR-TB RT-PCR demonstrated reliable performance for TB molecular diagnostic testing and can be implemented in routine TB diagnostic settings.
Keywords: INH resistance; Indigen; Mycobacterium tuberculosis; RIF resistance; diagnostic; real-time PCR.
Copyright © 2024 Parwati, Chaidir, Yunus, Montain, Budhiarko, Selasih, Ristandi, Rachman, Nurhayati, Pambudi and Budiyati.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Performance of Xpert MTB/RIF and sputum microscopy compared to sputum culture for diagnosis of tuberculosis in seven hospitals in Indonesia.Front Med (Lausanne). 2023 Jan 20;9:909198. doi: 10.3389/fmed.2022.909198. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36743681 Free PMC article.
-
Detection of Mycobacterium tuberculosis in AFB smear-negative sputum specimens through MTB culture and GeneXpert® MTB/RIF assay.Int J Immunopathol Pharmacol. 2019 Jan-Dec;33:2058738419827174. doi: 10.1177/2058738419827174. Int J Immunopathol Pharmacol. 2019. PMID: 30791749 Free PMC article.
-
Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.BMC Infect Dis. 2013 Oct 15;13:478. doi: 10.1186/1471-2334-13-478. BMC Infect Dis. 2013. PMID: 24128118 Free PMC article.
-
Abbott RealTime MTB and MTB RIF/INH assays for the diagnosis of tuberculosis and rifampicin/isoniazid resistance.Infect Genet Evol. 2019 Jul;71:54-59. doi: 10.1016/j.meegid.2019.03.012. Epub 2019 Mar 20. Infect Genet Evol. 2019. PMID: 30902741
-
Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults.Cochrane Database Syst Rev. 2019 Jun 7;6(6):CD009593. doi: 10.1002/14651858.CD009593.pub4. Cochrane Database Syst Rev. 2019. Update in: Cochrane Database Syst Rev. 2021 Feb 22;2:CD009593. doi: 10.1002/14651858.CD009593.pub5. PMID: 31173647 Free PMC article. Updated.
References
-
- Alisjahbana B., Koesoemadinata R. C., Hadisoemarto P. F., Lestari B. W., Hartati S., Chaidir L., et al. . (2021). Are neighbourhoods of tuberculosis cases a high-risk population for active intervention? A protocol for tuberculosis active case finding. PLoS One 16:e0256043. doi: 10.1371/journal.pone.0256043, PMID: - DOI - PMC - PubMed
-
- Araya B. T., Ali K. E., Geleta D. A., Tekele S. G., Tulu K. D. (2021). Performance of the Abbott RealTime MTB and RIF/INH resistance assays for the detection of mycobacterium tuberculosis and resistance markers in sputum specimens. PLoS One 16:e0251602. doi: 10.1371/journal.pone.0251602, PMID: - DOI - PMC - PubMed
-
- Armand S., Vanhuls P., Delcroix G., Courcol R., Lemaître N. (2011). Comparison of the Xpert MTB/RIF test with an IS6110-TaqMan real-time PCR assay for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J. Clin. Microbiol. 49, 1772–1776. doi: 10.1128/JCM.02157-10, PMID: - DOI - PMC - PubMed
-
- Babafemi E. O., Cherian B. P., Banting L., Mills G. A., Ngianga K. (2017). Effectiveness of real-time polymerase chain reaction assay for the detection of Mycobacterium tuberculosis in pathological samples: a systematic review and meta-analysis. Syst. Rev. 6:215. doi: 10.1186/s13643-017-0608-2, PMID: - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources